Michael S. Kinch, PhD

Associate Vice Chancellor and Professor

Washington University in St. Louis (WU)

Current emphasis is evaluating the science, medicine and business of biopharmaceutical research and development. Our team is assessing how new medicines are discovered and how this has changed, with an emphasis upon assuring that the activities can be sustained in the future.